Open tools that keep every message to a doctor true to the FDA label. Claim checks, label-change tracking, public-data HCP discovery and agent skills, for the teams that write to physicians and the reviewers who sign off.
openlabel check, built with OpenTUI
Check
openlabel checkEvery claim, traced to a sentence in the label. Pick one to see why.
Implies full clearance. 38% were clear or almost clear.
At Week 16, 38% of patients treated with LORVEXA achieved IGA 0 (clear) or 1 (almost clear), compared to 9% with placebo.
Watch
openlabel watchA label change has a blast radius. Watch finds the approved claims it broke and drafts the fixes.
Lorvexa label
rev 03/2026 to 06/20262.2 Recommended dosage
−Initial dose of 600 mg (two 300 mg injections),
+Initial dose of 400 mg (two 200 mg injections),
followed by 300 mg every other week.
5.3 Conjunctivitis and keratitis
+Conjunctivitis and keratitis occurred more frequently
+in patients who received LORVEXA.
4 fixes drafted and rechecked, 4 pass
Unseen
openlabel unseenFind the doctors nobody calls on. Built only from NPPES, CMS Part D, Open Payments and ClinicalTrials.gov.
❯Georgia dermatologists with heavy psoriasis prescribing and no industry contact in three years
| NPI | Specialty | Location | Psoriasis claims | Industry payments, 3 yrs | Trials |
|---|---|---|---|---|---|
| 1 4xx xxx 018 | Dermatology | Valdosta | 1,284 | $0 | 0 |
| 1 9xx xxx 377 | Dermatology | Albany | 1,102 | $0 | 0 |
| 1 2xx xxx 640 | Dermatology | Rome | 967 | $0 | 1 |
| 1 6xx xxx 205 | Dermatology | Waycross | 911 | $0 | 0 |
| 1 3xx xxx 852 | Dermatology | Dalton | 874 | $0 | 0 |
38 match, showing 5. Prescribing comes from CMS Part D, which runs about two years behind, so this view uses 2024 claims.
Skills
claude plugin install openlabel-skillsAgent skills for medical affairs. Each ships with the eval suite that grades it.
Eval run of October 17, 2026. Pick a skill to see its cases.